by Pandora Hughes | Feb 20, 2025 | Insights
Clinical Outcome Assessments and LGBTQIA+ Patients A transgender man takes part in a Patient Reported Outcome (PRO) assessment for a new drug. The firsttwo items he reads on the questionnaire are: What was your sex at birth, male or female? Do you menstruate? Why...
by Pandora Hughes | Nov 26, 2024 | Insights
Let’s try a little roleplay. Imagine you are a government official or a family doctor. You’re on a committee considering the licensing of a new drug. It’s the first meeting after lunch, so you’re not at your sharpest. You need the next session to be sharp and focused....
